Search research articles
Contact Us
Filters
Showing results (171-180 of 325) with videos related to
Page
of 33
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
College campuses and COVID-19 mitigation: clinical and economic value
Elena Losina, Valia Leifer, Lucia Millham, et al.
International Journal of Behavioral Medicine
|
May 9, 2022
Author Correction: Psychological Distress Increases 30-Fold Among People with HIV in the First Year on ART in Nigeria-a Call for Integrated Mental Health Services
Leslie J Pierce, Susan Regan, Ifeoma Idigbe, et al.
Nature Communications
|
October 30, 2021
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
Krishna P Reddy, Kieran P Fitzmaurice, Justine A Scott, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2021
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
Krishna P Reddy, Kieran P Fitzmaurice, Justine A Scott, et al.
The Journal of Infectious Diseases
|
December 19, 2015
Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
Rochelle P Walensky, Margo M Jacobsen, Linda-Gail Bekker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 2, 2010
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India
Melissa A Bender, Nagalingeswaran Kumarasamy, Kenneth H Mayer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire
Eugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.
Vaccine
|
September 15, 2004
A therapeutic HIV vaccine: how good is good enough?
Rochelle P Walensky, A David Paltiel, Sue J Goldie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States
Michael P Girouard, Paul E Sax, Robert A Parker, et al.
The Journal of Infectious Diseases
|
November 6, 2016
Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study
Krishna P Reddy, Robert A Parker, Elena Losina, et al.
Page
of 33
Search research articles
Search
Showing results (171-180 of 325) with videos related to
Sort By:
Page
of 33
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
College campuses and COVID-19 mitigation: clinical and economic value
Elena Losina, Valia Leifer, Lucia Millham, et al.
International Journal of Behavioral Medicine
|
May 9, 2022
Author Correction: Psychological Distress Increases 30-Fold Among People with HIV in the First Year on ART in Nigeria-a Call for Integrated Mental Health Services
Leslie J Pierce, Susan Regan, Ifeoma Idigbe, et al.
Nature Communications
|
October 30, 2021
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
Krishna P Reddy, Kieran P Fitzmaurice, Justine A Scott, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2021
Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
Krishna P Reddy, Kieran P Fitzmaurice, Justine A Scott, et al.
The Journal of Infectious Diseases
|
December 19, 2015
Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
Rochelle P Walensky, Margo M Jacobsen, Linda-Gail Bekker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 2, 2010
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India
Melissa A Bender, Nagalingeswaran Kumarasamy, Kenneth H Mayer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 31, 2010
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire
Eugène Messou, Marie-Laure Chaix, Delphine Gabillard, et al.
Vaccine
|
September 15, 2004
A therapeutic HIV vaccine: how good is good enough?
Rochelle P Walensky, A David Paltiel, Sue J Goldie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States
Michael P Girouard, Paul E Sax, Robert A Parker, et al.
The Journal of Infectious Diseases
|
November 6, 2016
Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study
Krishna P Reddy, Robert A Parker, Elena Losina, et al.
Page
of 33